New approach to cancer treatment shown to be highly effective
A novel monoclonal antibody targeting S1P has shown promising results in eliminating cancerous tumors in some cases. The therapy not only blocks the effects of S1P on cancer cells but also prevents tumor angiogenesis, a key factor in tumor growth.